Cargando…
Response to ‘Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study’
Autores principales: | Ikari, Katsunori, Yano, Koichiro, Yoshida, Shinji, Taniguchi, Atsuo, Yamanaka, Hisashi, Momohara, Shigeki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145539/ https://www.ncbi.nlm.nih.gov/pubmed/25263166 http://dx.doi.org/10.1186/s13075-014-0422-3 |
Ejemplares similares
-
Peptidyl Arginine Deiminase 2 (PADI2)-Mediated Arginine Citrullination Modulates Transcription in Cancer
por: Beato, Miguel, et al.
Publicado: (2020) -
Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study
por: Bang, So-Young, et al.
Publicado: (2010) -
PADI4 and HLA-DRB1 Are Genetic Risks for Radiographic Progression in RA Patients, Independent of ACPA Status: Results from the IORRA Cohort Study
por: Suzuki, Taku, et al.
Publicado: (2013) -
PADI6: What we know about the elusive fifth member of the peptidyl arginine deiminase family
por: Williams, Jack P. C., et al.
Publicado: (2023) -
Murine Retinal Citrullination Declines With Age and is Mainly Dependent on Peptidyl Arginine Deiminase 4 (PAD4)
por: Hollingsworth, T. J., et al.
Publicado: (2018)